Literature DB >> 20837309

Novel LMNA mutation presenting as severe congenital muscular dystrophy.

Cynthia Prigogine1, Pascale Richard, Peter Van den Bergh, José Groswasser, Nicolas Deconinck.   

Abstract

Mutations in the lamin A/C gene determine a heterogeneous group of congenital diseases, termed laminopathies, consisting of more than 15 phenotypes, including autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy type 1B. Early onset in infancy has been described in these muscular dystrophies. Reported here is a 7-year-old male with congenital muscular dystrophy. Remarkably, muscle weakness and wasting affected predominantly axial muscles as well as proximal upper and distal lower extremities. The patient rapidly developed joint contractures and spine rigidity with the head only mildly flexed. Serum creatine kinase was moderately elevated. Muscle biopsy indicated a dystrophic pattern with normal immunochemical findings. A novel, de novo missense substitution p.Asn39Tyr within the lamin A/C gene confirmed the diagnosis of a laminopathy. This report broadens the spectrum of lamin A/C gene mutations and illustrates the phenotypic variability of laminopathies with early onset congenital muscular dystrophy. Mutations in the lamin A/C gene should be sought in any infant with dystrophic features and normal tissue immunochemical studies; especially in the presence of moderately elevated serum creatine kinase, predominant axial and humeroperoneal weakness, spine rigidity, and joint contractures.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837309     DOI: 10.1016/j.pediatrneurol.2010.05.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

Review 1.  Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations.

Authors:  Howard J Worman
Journal:  Biochem Soc Trans       Date:  2017-12-01       Impact factor: 5.407

Review 2.  RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.

Authors:  Jian Liu; Scott Q Harper
Journal:  Curr Gene Ther       Date:  2012-08       Impact factor: 4.391

3.  A Novel Lamin A Mutant Responsible for Congenital Muscular Dystrophy Causes Distinct Abnormalities of the Cell Nucleus.

Authors:  Alice Barateau; Nathalie Vadrot; Patrick Vicart; Ana Ferreiro; Michèle Mayer; Delphine Héron; Corinne Vigouroux; Brigitte Buendia
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

4.  Diagnostic approach to the congenital muscular dystrophies.

Authors:  Carsten G Bönnemann; Ching H Wang; Susana Quijano-Roy; Nicolas Deconinck; Enrico Bertini; Ana Ferreiro; Francesco Muntoni; Caroline Sewry; Christophe Béroud; Katherine D Mathews; Steven A Moore; Jonathan Bellini; Anne Rutkowski; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2014-01-09       Impact factor: 4.296

5.  A novel LMNA mutation identified in a Japanese patient with LMNA-associated congenital muscular dystrophy.

Authors:  Akihiko Ishiyama; Aritoshi Iida; Shinichiro Hayashi; Hirofumi Komaki; Masayuki Sasaki; Ikuya Nonaka; Satoru Noguchi; Ichizo Nishino
Journal:  Hum Genome Var       Date:  2018-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.